Secondly, since none of the available METTL17 antibodies met our immunofluorescence quality standards, we generated a C-terminal Flag-tagged METTL17 construct, which was overexpressed in CRC cells (Fig. 4B). Here, METTL17 is linked to colorectal carcinoma.